EUVIMEDTutustu EUVIMEDiin
Open access · CC BY 4.0

Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia

Matthew Chung Yi Koh, Jinghao Nicholas Ngiam, Lionel Hon-Wai Lum, Nares Smitasin, Ka Lip Chew, David Michael Allen

Journal of Infection and Public Health · 2025-08 · 18 (8) · 102829

DOI: 10.1016/j.jiph.2025.102829 ↗

At a glance

Journal article in Journal of Infection and Public Health, 2025-08. Written by Matthew Chung Yi Koh and 5 co-authors. Institution: Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore. Electronic address: matthew.koh@mohh.com.sg. Major MEDLINE topics: Stenotrophomonas maltophilia, Gram-Negative Bacterial Infections, Bacteremia, Anti-Bacterial Agents. Cited 8 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0).

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

BACKGROUND: Stenotrophomonas maltophilia is an important nosocomial pathogen. Bacteraemia is associated with significant morbidity, despite antibiotic therapy. Optimal treatment strategies for Stenotrophomonas maltophilia bacteraemia remain ill-defined. Thus, we retrospectively examined the clinical presentation, microbiological characteristics, treatment options to identify risk factors for mortality. METHODS: We performed a retrospective single-centre analysis of Stenotrophomonas maltophilia bacteraemia from 1 Jan 2012-30 Jun 2024. Data on the clinical presentation, source of infection, microbiological characteristics, treatment strategies and clinical outcomes were tabulated. Risk factors for in-hospital all-cause mortality were identified by appropriate univariate and multivariable analyses. RESULTS: There were 197 bacteraemia episodes. In-hospital mortality was 41.6 % (n = 82), and did not change significantly over the years. Patients who died were more likely to have prior carbapenem exposure (81.7 % vs 53.0 %, p < 0.001), presentation in an intensive care (ICU) setting (73.2 % vs 15.7 %, p < 0.001), and had a longer duration of fever (8.5 ± 2.5 vs 3.0 ± 3.8 days, p < 0.001). Microbiological isolation from additional sites other than the blood (e.g. sputum culture positivity) also correlated with mortality (39.0 % vs 7.8 %, p < 0.001). Over time, proportion of isolates resistant to fluoroquinolones increased. An initial antimicrobial choice containing trimethoprim-sulfamethoxazole appeared to be more likely to be associated with survival. Only 13 patients (6.6 %) received dual antibiotics initially, so it was unclear if this was associated with better outcomes. On multivariable analysis, ICU onset, elevated C-reactive protein, longer duration of fever and an absence of intervention for source control remained independently associated with mortality. CONCLUSIONS: Source control of infection may be critical in improving survival in Stenotrophomonas maltophilia bacteraemia. Future prospective studies should validate important risk factors for mortality and define optimal antimicrobial treatment strategies.

Subjects

MeSH terms (MEDLINE)

Stenotrophomonas maltophiliaGram-Negative Bacterial InfectionsBacteremiaAnti-Bacterial AgentsHumansRetrospective StudiesMaleFemaleRisk FactorsAgedMiddle AgedAged, 80 and overHospital MortalityAdult

Author keywords

Antibiotic treatmentBacteraemiaBloodstream infectionCarbapenem-resistantMortalityRisk factorsStenotrophomonas maltophilia

Substances

Anti-Bacterial Agents

Authors and institutions

  • Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore. Electronic address: matthew.koh@mohh.com.sg.
  • Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore. Electronic address: nicholas_ngiam@nuhs.edu.sg.
  • Division of Infectious Diseases, Department of Medicine, National University Health System, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic add…
  • Department of Laboratory Medicine, National University Hospital, Singapore. Electronic address: Ka_lip_chew@nuhs.edu.sg.

Cite

APA

Koh, M. C. Y., Ngiam, J. N., Lum, L. H., Smitasin, N., Chew, K. L., & Allen, D. M. (2025). Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia. Journal of Infection and Public Health, 18(8), 102829. https://doi.org/10.1016/j.jiph.2025.102829

Vancouver

Koh MCY, Ngiam JN, Lum LH, Smitasin N, Chew KL, Allen DM. Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia. Journal of Infection and Public Health. 2025;18(8):102829. doi:10.1016/j.jiph.2025.102829

BibTeX
@article{Koh2025,
  author = {Koh, Matthew Chung Yi and Ngiam, Jinghao Nicholas and Lum, Lionel Hon-Wai and Smitasin, Nares and Chew, Ka Lip and Allen, David Michael},
  title = {Risk factors for mortality and implications on therapy for Stenotrophomonas maltophilia bacteraemia},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  volume = {18},
  number = {8},
  pages = {102829},
  doi = {10.1016/j.jiph.2025.102829}
}
Start for free →